Drug intelligence / Profile preview

morphine + acetaminophen

Development stage
Unknown
Lead developer
Eslam Ayman Mohamed Shawki
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

The I.V drug-Eslam Ayman Mohamed Shawki-postoperative pain refers to a specific multimodal analgesic regimen utilized as a control arm in clinical research led by Eslam Ayman Mohamed Shawki, specifically for managing pain following lumbar spine surgery. This regimen consists of a baseline intravenous (I.V.) morphine dose of 5 mg administered every 8 hours, supplemented by rescue I.V. morphine in 2.5 mg increments for breakthrough pain (defined as a VAS score ≥ 4). Additionally, the regimen includes scheduled oral acetaminophen at a dose of 1 gm every 6 hours. Morphine provides systemic analgesia by acting as an agonist at mu-opioid receptors in the central nervous system, while acetaminophen provides complementary non-opioid pain relief through the inhibition of prostaglandin synthesis. This combination is designed to serve as a standard-of-care comparator for evaluating the efficacy of regional anesthesia techniques such as the Thoracolumbar Interfascial Plane (TLIP) block.

Other names
I.V drug based multimodal approachmorphine and acetaminophen multimodal regimen
02

Targets

MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on morphine + acetaminophen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morphine + acetaminophen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call